In partnership with leading ayahuasca experts, the Chacruna Institute published an article in the Journal of Psychedelic Studies in response to the DEA's 2020 ayahuasca report.
SAN FRANCISCO, June 20, 2023 /PRNewswire-PRWeb/ -- In February 2023, the Drug Enforcement Administration (DEA) released a document to the legal team representing the Church of the Eagle and the Condor (CEC). This disclosure came two years after the CEC and the Chacruna Institute for Psychedelic Plant Medicines submitted two FOIA requests to the DEA and the Department of Justice requesting all records pertaining to ayahuasca.
The report, titled "Ayahuasca: Risks to Public Health and Safety," was issued in July 2020. It takes a very clear stance against the use of ayahuasca, claiming that it presents a significant risk to public health and safety. According to contributors from the Chacruna Institute, the report is in line with the prohibitionist approach of the US government, which has continued to target ayahuasca groups through seizures, arrests and other actions. The report is also a strong indication that the government will be resistant to recognizing religious minorities and traditional populations' rights.
On June 9, 2023, the Chacruna Institute published an article in the peer-reviewed Journal of Psychedelic Studies contesting the DEA's report. The article, "The DEA Report on Ayahuasca Risks: 'Science' in Service of Prohibition?" was written in partnership with leading experts on ayahuasca, including scholars from the fields of biology, neuroscience, psychology, psychiatry, anthropology, and sociology.
The article challenges a number of assertions made by the DEA, highlighting significant factual omissions, theoretical biases, and misinterpretations of existing data. The article highlights how the DEA report severely downplays the safety profile and therapeutic potential of ayahuasca, ignores a vast body of epidemiological evidence from its use among Indigenous and religious communities around the world, and overemphasizes the risks, while failing to include current research on ayahuasca demonstrating its potential benefits.
Chacruna Institute members assert that this shows that the prohibitionist paradigm and the persecution of ethnic and religious minorities will not be ignored and that the global scientific community is taking a stand against the criminalization of ayahuasca. If you want to read the full critique of the DEA's report, click here: https://akjournals.com/view/journals/2054/aop/article-10.1556-2054.2023.00279/article-10.1556-2054.2023.00279.xml?body=fullhtml-26185. To support this kind of critical psychedelic scholarship, please consider donating to support Chacruna's mission.
About Chacruna Institute
The Chacruna Institute for Psychedelic Plant Medicines, is a 501(c)(3) non-profit organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist Dr. Clancy Cavnar, based in Northern California and with strong ties to Brazil and Mexico. We promote reciprocity in the psychedelic community, and support the protection of sacred plants and cultural traditions. We advance psychedelic justice through curating critical conversations and uplifting the voices of women, queer people, Indigenous peoples, people of color, and the Global South in the field of psychedelic science.
Media Contact
Lorien Chavez, Chacruna Institute for Psychedelic Plant Medicines, 1 415-390-6157, [email protected]
SOURCE Chacruna Institute for Psychedelic Plant Medicines
Share this article